Physician profile
Timothy Carter
NPI 1720304074
$14,331.42
in general payments reported to CMS, 2019-2025
22 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,015 · 2020: $1,707 · 2021: $828 · 2022: $2,773 · 2023: $2,415 · 2024: $2,291 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,920 · Travel and Lodging: $2,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,919.86 |
| Travel and Lodging | $2,088.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $5,038.74 | 2019-2025 | Cardiac Non-Synergraft, Cryovalve Sg Pulmonary Human Heart Valve, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Medtronic, INC. | $2,073.50 | 2022-2025 | Valiant Captivia, Corevalve Evolut R, Endurant Iis |
| Edwards Lifesciences Corporation | $1,989.72 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Carpentier-Edwards Physio II Annuloplasty Ring |
| Medtronic Vascular, INC. | $1,753.02 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $595.62 | 2023 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Kestra Medical Technology Services, INC. | $584.22 | 2022-2025 | Assure Wcd |
| Abbott Laboratories | $443.17 | 2020-2025 | Mitraclip, Aveir, Navitor |
| Atricure, INC. | $364.90 | 2020-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Cook Medical LLC | $243.63 | 2021-2025 | Cook |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $234.05 | 2019-2024 | Lifevest |
| Abiomed | $218.36 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $190.44 | 2019 | |
| Janssen Pharmaceuticals, INC | $188.34 | 2019-2024 | Xarelto |
| Philips North America LLC | $111.30 | 2019 | |
| Ekos Corporation | $96.58 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $43.53 | 2019-2021 | |
| Lemaitre Vascular, INC. | $41.98 | 2023-2025 | Tyke, Patch, Pledget and Intracardiac, Restoreflow |
| Zimvie INC. | $37.97 | 2022 | |
| Bolton Medical INC | $29.89 | 2019-2021 | |
| Angiodynamics, INC. | $25.90 | 2025 | Angiovac |
| Zimmer Biomet Holdings, INC. | $13.85 | 2023 | Sternalock Blu System |
| Chiesi USA, INC. | $12.71 | 2023 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.